East Coast Pharmaceutical Inc is categorized under Direct Selling Establishments in Fort Lauderdale, FL and active since 2001.
East Coast Pharmaceutical Inc was established in 2001, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Direct Selling Establishments business, which does work in the B2C market, and is classified as a Direct Selling Establishments, under code number 454390 by the NAICS.
If you are seeking more information, feel free to contact Ginny Wills at the company’s single location by writing to 1380 Nw 103rd Terrace, Fort Lauderdale, Florida FL 33322 or by phoning (307) 754-7178. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | East Coast Pharmaceutical Inc |
Contact Person: | Ginny Wills |
Address: | 1380 Nw 103rd Terrace, Fort Lauderdale, Florida 33322 |
Phone Number: | (307) 754-7178 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Direct Selling Establishments |
SIC Code: | 5963 |
NAICS Code: | 454390 |
Share This Business: |
East Coast Pharmaceutical Inc was started in 2001 to provide professional Direct Selling Establishments under the SIC code 5963 and NAICS code 454390. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Ginny Wills for inquiries that concern East Coast Pharmaceutical Inc by calling the company number (307) 754-7178, as your correspondence is most welcome. Additionally, the physical location of the single location of East Coast Pharmaceutical Inc can be found at the coordinates 26.140873,-80.287617 as well as the street address 1380 Nw 103rd Terrace in Fort Lauderdale, Florida 33322.
For its online presence, you may visit East Coast Pharmaceutical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.